GlassScriptPhysician profile
Erin Meade Duncan
NPI 1982047817
$625.18
in general payments reported to CMS, 2019-2025
20 companies · $97.57 in 2025
The $97.57 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $73.22 · 2022: $50.36 · 2023: $161 · 2024: $131 · 2025: $97.57.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $389.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $95.52 | 2019-2025 | |
| Abbvie INC. | $58.21 | 2019-2023 | Lo Loestrin Fe |
| Astellas Pharma US INC | $51.47 | 2023-2024 | Veozah |
| Shield Therapeutics INC | $46.12 | 2024 | |
| Mayne Pharma Commercial LLC | $42.05 | 2022-2023 | |
| Hologic Sales and Service, LLC | $40.15 | 2025 | Thinprep 2000 Processor, Aptima |
| Therapeuticsmd, INC. | $37.21 | 2019 | |
| Sage Therapeutics, LLC | $32.83 | 2023 | |
| Pfizer INC. | $32.16 | 2024 | |
| Organon LLC | $31.95 | 2024 | |
| Dexcom, INC. | $19.63 | 2025 | Dexcom G6 Transmitter |
| Ascend Therapeutics US, LLC | $17.86 | 2023 | |
| Coopersurgical, INC. | $17.71 | 2025 | Paragard T 380a |
| Medicem INC. | $17.03 | 2023 | |
| Exeltis, USA INC. | $16.56 | 2023 | Slynd |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amag Pharmaceuticals, INC. | $15.81 | 2019 | |
| Allergan, INC. | $14.94 | 2020 | |
| Vertical Pharmaceuticals, LLC | $13.69 | 2019 | |
| Lupin INC. | $13.25 | 2020 | |
| Roche Diagnostics Corporation | $11.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Duncan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.